The anti-inflammatory effect was consistent with that reported in a previous study, where OI activated Nrf2 signaling to inhibit proinflammatory cytokine secretion in the PBMCs of systemic lupus erythematosus patients (Tang et al. 2018). The gene discussed is NFE2L2; the disease is systemic lupus erythematosus.